These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7947266)

  • 21. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
    Kumar S; Witzig TE; Greipp PR; Rajkumar SV
    Br J Haematol; 2003 Jul; 122(2):272-4. PubMed ID: 12846897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
    Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
    Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses.
    Omedè P; Tarella C; Palumbo A; Argentino C; Caracciolo D; Corradini P; Dominietto A; Giaretta F; Ravaglia R; Triolo R; Triolo S; Pileri A; Boccadoro M
    Br J Haematol; 1997 Dec; 99(3):685-91. PubMed ID: 9401085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
    Gonsalves WI; Rajkumar SV; Dispenzieri A; Dingli D; Timm MM; Morice WG; Lacy MQ; Buadi FK; Go RS; Leung N; Kapoor P; Hayman SR; Lust JA; Russell SJ; Zeldenrust SR; Hwa L; Kourelis TV; Kyle RA; Gertz MA; Kumar SK
    Leukemia; 2017 Jan; 31(1):130-135. PubMed ID: 27457702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics.
    Omedè P; Boccadoro M; Fusaro A; Gallone G; Pileri A
    Br J Haematol; 1993 Nov; 85(3):504-13. PubMed ID: 8136273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
    Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
    Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colony growth and self renewal of plasma cell precursors in multiple myeloma.
    Takahashi T; Lim B; Jamal N; Tritchler D; Lockwood G; McKinney S; Bergsagel DE; Messner HA
    J Clin Oncol; 1985 Dec; 3(12):1613-23. PubMed ID: 4067612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating peripheral blood plasma cells in multiple myeloma.
    Witzig TE; Kyle RA; Greipp PR
    Curr Top Microbiol Immunol; 1992; 182():195-9. PubMed ID: 1490354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple myeloma in serologic complete remission after autologous stem cell transplantation: impact of bone marrow plasma cell assessment by conventional morphology on disease progression.
    Fernández de Larrea C; Tovar N; Rozman M; Rosiñol L; Aróstegui JI; Cibeira MT; Rovira M; Yagüe J; Bladé J
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1084-7. PubMed ID: 21215814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma.
    Ravi P; Kumar S; Larsen JT; Gonsalves W; Buadi F; Lacy MQ; Go R; Dispenzieri A; Kapoor P; Lust JA; Dingli D; Lin Y; Russell SJ; Leung N; Gertz MA; Kyle RA; Bergsagel PL; Rajkumar SV
    Blood Cancer J; 2016 Jul; 6(7):e454. PubMed ID: 27471870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.
    Steensma DP; Gertz MA; Greipp PR; Kyle RA; Lacy MQ; Lust JA; Offord JR; Plevak MF; Therneau TM; Witzig TE
    Blood; 2001 Apr; 97(8):2522-3. PubMed ID: 11290618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation.
    Gertz MA; Witzig TE; Pineda AA; Greipp PR; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1997 Feb; 19(4):337-42. PubMed ID: 9051243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
    Vagnoni D; Travaglini F; Pezzoni V; Ruggieri M; Bigazzi C; Dalsass A; Mestichelli F; Troiani E; Falcioni S; Mazzotta S; Natale A; Angelini M; Ferretti S; Angelini S; Galieni P
    Br J Haematol; 2015 Aug; 170(4):523-31. PubMed ID: 26010293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.